Recent Updates
Recently added Catalysts
TRIB Positive Sentiment Score: 70/100

Trinity Biotech to Present at Emerging Growth Conference

Thursday, February 8, 2024 1 min read
Key Takeaway: Trinity Biotech plc will present virtually at the Emerging Growth Conference on March 7, 2024. The presentation invites both individual and institutional investors, alongside advisors and analysts, to engage in a real-time interactive session. Trinity Biotech develops diagnostic systems aimed at both point-of-care and clinical laboratory markets, with a global presence across multiple countries.

Market Sentiment Analysis

POSITIVE FACTORS

  • Trinity Biotech is actively engaging with investors at a significant conference.
  • The presentation offers an interactive platform for real-time discussions.
  • Highlighting its products and market engagement can increase visibility and investor interest.

Full Press Release Details

DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on March 7, 2024. The Company invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. Please see the presentation information below.
Presentation Details
Date: Thursday, March 7, 2024
Time: 11:25 – 11:55 AM ET
Registration: https://goto.webcasts.com/starthere.jsp?ei=1650531&tp_key=ca9510e531&sti=trib
About Trinity Biotech Plc
Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: www.trinitybiotech.com

Frequently Asked Questions

When is Trinity Biotech's virtual presentation scheduled?

The virtual presentation is on March 7, 2024, from 11:25 to 11:55 AM ET.

Who can attend the Emerging Growth Conference presentation?

Individual and institutional investors, advisors, and analysts are invited.

What does Trinity Biotech specialize in?

Trinity Biotech develops diagnostic systems for detecting infectious diseases.

In which countries does Trinity Biotech sell its products?

Trinity Biotech sells directly in the U.S., Germany, France, and the U.K.

How can I register for the Trinity Biotech presentation?

You can register at https://goto.webcasts.com/starthere.jsp?ei=1650531&tp_key=ca9510e531&sti=trib.

Tags: TRIB Viatris Investor Conferences Healthcare Trinity Biotech trading investors diagnostics Emerging Growth Conference
Last updated: Feb 8, 2024